Trinity Biotech (TRIB) Revenue (QoQ) (2009 - 2024)
Trinity Biotech (TRIB) Revenue (QoQ) (2009 - 2024) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn |
| 10 | Trinity Biotech | 107.74 Mn | 102.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4.65% |
| Sep 30, 2024 | -4.36% |
| Jun 30, 2024 | 7.75% |
| Mar 31, 2024 | 9.50% |
| Dec 31, 2023 | -8.51% |
| Sep 30, 2023 | 5.61% |
| Jun 30, 2023 | -6.28% |
| Mar 31, 2023 | -5.70% |
| Dec 31, 2022 | 0.13% |
| Sep 30, 2022 | 1.87% |
| Jun 30, 2022 | -1.65% |
| Mar 31, 2022 | -19.72% |
| Dec 31, 2021 | -11.27% |
| Sep 30, 2021 | -14.86% |
| Jun 30, 2021 | 0.97% |
| Mar 31, 2021 | -21.89% |
| Dec 31, 2020 | 2.35% |
| Sep 30, 2020 | 99.79% |
| Jun 30, 2020 | -24.33% |
| Mar 31, 2020 | -0.66% |